UK travellers who take out travel insurance but do not declare weight-loss injections may face higher costs or coverage problems if they become ill while abroad, according to reporting citing the importance of accurate medical disclosures.
The coverage issue arises because travel insurers typically require applicants to declare relevant medical conditions and treatments so policies can be priced and eligibility can be assessed. Sources highlight that many people are not disclosing these medications when buying holiday cover, raising the risk of disputes over claims.
The accounts focus on the potential financial impact for policyholders, including the possibility of unexpected bills if an insurer rejects or limits a claim due to incomplete information. They do not provide specific figures on how many claims are denied, but they emphasise that failure to declare can affect the outcome of insurance reimbursement.
